Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease

Nephron

Volumn 135, Issue 1, 2017, Pages 51-60

  Kikuchi, Mami ^b   Ueno, Mariko ^b   Itoh, Yoshiharu ^b   Suda, Wataru ^a,c   Hattori, Masahira ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b KUREHA CORPORATION   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d WASEDA UNIVERSITY   (Japan)

Author keywords

16S rRNA; AST 120; Chronic kidney disease; Gut microbiota; Pyrosequencing; Uremic toxin

Indexed keywords

AST 120; INDICAN; INDOLE; PHENOL; RNA 16S; TRYPTOPHANASE; TYROSINE PHENOL LYASE; UREMIC TOXIN; BACTERIAL RNA; PHENYLSULFATE; SULFATE; TOXIN; UREMIA MIDDLE MOLECULE TOXINS;

ANAEROTRUNCUS COLIHOMINIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDETES; CHRONIC KIDNEY FAILURE; CLOSTRIDIA; CLOSTRIDIUM; CLOSTRIDIUM CITRONIAE; CLOSTRIDIUM SACCHAROLYTICUM; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ESCHERICHIA; FECES MICROFLORA; FIRMICUTES; GAMMAPROTEOBACTERIA; INTESTINE FLORA; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; MALE; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; PARABACTEROIDES; PRIORITY JOURNAL; PYROSEQUENCING; RAT; RNA SEQUENCE; TANDEM MASS SPECTROMETRY; URINARY EXCRETION; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; BACTEROIDETES; CLOSTRIDIUM; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; HUMANS; INDICAN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SULFURIC ACID ESTERS; TOXINS, BIOLOGICAL;

EID: 84990226180     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000450619     Document Type: Article

References (32)

1. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A; European Uremic Toxin Work Group: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 2012; 23: 1258-1270
2. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group (EUTox): Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943
3. Niwa T, Ise M: Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994; 124: 96-104
4. Lekawanvijit S, Kompa AR, Wang BH, Kelly DJ, Krum H: Cardiorenal syndrome: the emerging role of protein-bound uremic toxins. Circ Res 2012; 111: 1470-1483
5. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uremic Toxin Work Group (EUTox): Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 1551-1558
6. Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G: The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol 2014; 25: 1897-1907
7. Schepers E, Glorieux G, Vanholder R: The gut: the forgotten organ in uremia? Blood Purif 2010; 29: 130-136
8. Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW: Colonic contribution to uremic solutes. J Am Soc Nephrol 2011; 22: 1769-1776
9. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G: Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 2009; 106: 3698-3703
10. Meyer TW, Hostetter TH: Uremic solutes from colon microbes. Kidney Int 2012; 81: 949-954
11. Schulman G, Vanholder R, Niwa T: AST-120 for the management of progression of chronic kidney disease. Int J Nephrol Renovasc Dis 2014; 7: 49-56
12. Lee WJ, Hase K: Gut microbiota-generated metabolites in animal health and disease. Nat Chem Biol 2014; 10: 416-424
13. Ramezani A, Raj DS: The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 2014; 25: 657-670
14. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL: Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013; 83: 308-315
15. Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS: Role of the gut microbiome in uremia: a potential therapeutic target. Am J Kidney Dis 2016; 67: 483-498
16. Kurokawa A, Ikeda S, Hagiwara T, Sukemori S, Kurihara Y: Effects of cecectomy on digestion and retention time of digesta in rats. Anim Sci J 2007; 78: 47-54
17. Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T: Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/ tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878: 2997-3002
18. Ueno M, Kikuchi M, Oshima K, Kim S, Morita H, Hattori M: Assessment and improvement of methods for microbial DNA preparation from fecal samples; in Bruijin FJ (ed): Handbook of Molecular Microbial Ecology II. Hoboken, John Wiley &Sons, Inc., 2011, pp 191-198
19. Said HS, Suda W, Nakagome S, Chinen H, Oshima K, Kim S, Kimura R, Iraha A, Ishida H, Fujita J, Mano S, Morita H, Dohi T, Oota H, Hattori M: Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res 2014; 21: 15-25
20. Kim SW, Suda W, Kim S, Oshima K, Fukuda S, Ohno H, Morita H, Hattori M: Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res 2013; 20: 241-253
21. Phillips RS, Demidkina TV, Faleev NG: Structure and mechanism of tryptophan indolelyase and tyrosine phenol-lyase. Biochim Biophys Acta 2003; 1647: 167-172
22. Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S: Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Am J Nephrol 2013; 38: 99-103
23. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS: Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant 2012; 27: 2686-2693
24. Yoshifuji A, Wakino S, Irie J, Tajima T, Hasegawa K, Tokuyama H, Hayashi K, Itoh H: Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats. Nephrol Dial Transplant 2016; 31: 401-412
25. Vaziri ND, Yuan J, Khazaeli M, Masuda Y, Ichii H, Liu S: Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption. Am J Nephrol 2013; 37: 518-525
26. Lee JH, Lee J: Indole as an intercellular signal in microbial communities. FEMS Microbiol Rev 2010; 34: 426-444
27. Melander RJ, Minvielle MJ, Melander C: Controlling bacterial behavior with indole-containing natural products and derivatives. Tetrahedron 2014; 70: 6363-6372
28. Weber D, Oefner PJ, Hiergeist A, Koestler J, Gessner A, Weber M, Hahn J, Wolff D, Stammler F, Spang R, Herr W, Dettmer K, Holler E: Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood 2015; 126: 1723-1728
29. Voravuthikunchai SP, Lee A: Cecectomy causes long-term reduction of colonization resistance in the mouse gastrointestinal tract. Infect Immun 1987; 55: 995-999
30. Lawson PA, Song Y, Liu C, Molitoris DR, Vaisanen ML, Collins MD, Finegold SM: Anaerotruncus colihominis gen. nov., sp. nov., from human faeces. Int J Syst Evol Microbiol 2004; 54(pt 2):413-417
31. Warren YA, Tyrrell KL, Citron DM, Goldstein EJ: Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections. J Clin Microbiol 2006; 44: 2416-2422
32. Challand MR, Martins FT, Roach PL: Catalytic activity of the anaerobic tyrosine lyase required for thiamine biosynthesis in Escherichia coli. J Biol Chem 2010; 285: 5240-5248